| Authors: |
Park SS; Asan Institute for Life Sciences, ASAN Medical Center, Seoul, Republic of Korea. pssooni.park@samsung.com.; Asan Preclinical Evaluation Center for Cancer Therapeutix, ASAN Medical Center, Seoul, Republic of Korea. pssooni.park@samsung.com.; Medical Research Institute, Kangbuk Samsung Hospital, Seoul, Republic of Korea. pssooni.park@samsung.com., Lee HW; Asan Institute for Life Sciences, ASAN Medical Center, Seoul, Republic of Korea.; Asan Medical Institute of Convergence Science and Technology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Kwon MR; Asan Institute for Life Sciences, ASAN Medical Center, Seoul, Republic of Korea.; Asan Preclinical Evaluation Center for Cancer Therapeutix, ASAN Medical Center, Seoul, Republic of Korea., Ju EJ; Asan Institute for Life Sciences, ASAN Medical Center, Seoul, Republic of Korea.; Asan Preclinical Evaluation Center for Cancer Therapeutix, ASAN Medical Center, Seoul, Republic of Korea., Shin SH; Asan Institute for Life Sciences, ASAN Medical Center, Seoul, Republic of Korea.; Asan Preclinical Evaluation Center for Cancer Therapeutix, ASAN Medical Center, Seoul, Republic of Korea., Park J; Asan Institute for Life Sciences, ASAN Medical Center, Seoul, Republic of Korea.; Asan Preclinical Evaluation Center for Cancer Therapeutix, ASAN Medical Center, Seoul, Republic of Korea., Ko EJ; Asan Institute for Life Sciences, ASAN Medical Center, Seoul, Republic of Korea.; Asan Preclinical Evaluation Center for Cancer Therapeutix, ASAN Medical Center, Seoul, Republic of Korea., Son GW; Asan Institute for Life Sciences, ASAN Medical Center, Seoul, Republic of Korea.; Asan Medical Institute of Convergence Science and Technology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Kim YJ; Department of Radiation Oncology, ASAN Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Moon GJ; Department of Convergence Medicine, ASAN Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.; Center for Cell Therapy, ASAN Medical Center, Seoul, Republic of Korea., Kim DH; Department of Convergence Medicine, ASAN Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Choi YJ; Department of Convergence Medicine, ASAN Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Rho JK; Department of Convergence Medicine, ASAN Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Park YY; Department of Life Science, Chung-Ang University, Seoul, Republic of Korea., Kim TW; Asan Preclinical Evaluation Center for Cancer Therapeutix, ASAN Medical Center, Seoul, Republic of Korea.; Department of Oncology, ASAN Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Song SY; Asan Preclinical Evaluation Center for Cancer Therapeutix, ASAN Medical Center, Seoul, Republic of Korea. coocoori@amc.seoul.kr.; Department of Radiation Oncology, ASAN Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. coocoori@amc.seoul.kr., Jeong SY; Asan Institute for Life Sciences, ASAN Medical Center, Seoul, Republic of Korea. syj@amc.seoul.kr.; Asan Preclinical Evaluation Center for Cancer Therapeutix, ASAN Medical Center, Seoul, Republic of Korea. syj@amc.seoul.kr.; Department of Convergence Medicine, ASAN Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. syj@amc.seoul.kr. |
